Architecting Resilient Pharmaceutical Supply Chains: Strategic Management Approaches for Medication Availability in an Era of Global Disruptions

Pharmaceutical supply chains are increasingly exposed to disruptions arising from concentrated manufacturing, limited sources of active pharmaceutical ingredients and critical materials, quality failures, transportation constraints, demand volatility, geopolitical instability, and regulatory dependencies. These vulnerabilities are particularly consequential because interruptions in pharmaceutical supply can affect medication availability and continuity of patient care. This study develops a strategic management framework for pharmaceutical supply resilience centered on the ability to protect medication availability under uncertain operating conditions. The framework integrates six capabilities: Anticipate, Diversify, Buffer, Detect, Coordinate, and Recover . Anticipation identifies critical dependencies before disruption occurs; diversification reduces exposure to common points of failure; buffering provides targeted protection for medicines whose recovery or substitution may require time; detection creates an early-warning capability based on supply, inventory, and demand signals; coordination connects manufacturers, distributors, procurement teams, pharmacists, clinicians, quality functions, and regulatory actors; and recovery links restoration of supply with organizational learning. The framework emphasizes differentiated resilience strategies based on medication criticality, supply concentration, substitutability, lead time, and recovery capability instead of uniform increases in inventory or supplier numbers. Pharmacy operations are incorporated as a key interface between upstream supply conditions and clinical demand, providing evidence of emerging shortages and their operational consequences. The study further examines how strategic sourcing, risk-adjusted inventory, digital visibility, quality management, and regulatory coordination can strengthen continuity while preserving pharmaceutical standards and economic sustainability. By connecting preparedness, response, and recovery within a single management architecture, the framework provides a practical basis for strengthening pharmaceutical supply continuity in environments characterized by increasingly interconnected disruptions.

Authors

Publication Details

Journal
International Journal of Research Publications
Published
2026-11-17
DOI
https://doi.org/10.47119/ijrp1002071111020269867
Primary Topic
Supply Chain Resilience and Risk Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Architecting Resilient Pharmaceutical Supply Chains: Strategic Management Approaches for Medication Availability in an Era of Global Disruptions

Maysa Meredova
4 links
International Journal of Research Publications
Supply Chain Resilience and Risk Management
article

Architecting Resilient Pharmaceutical Supply Chains: Strategic Management Approaches for Medication Availability in an Era of Global Disruptions

Maysa Meredova
article en

Abstract

Pharmaceutical supply chains are increasingly exposed to disruptions arising from concentrated manufacturing, limited sources of active pharmaceutical ingredients and critical materials, quality failures, transportation constraints, demand volatility, geopolitical instability, and regulatory dependencies. These vulnerabilities are particularly consequential because interruptions in pharmaceutical supply can affect medication availability and continuity of patient care. This study develops a strategic management framework for pharmaceutical supply resilience centered on the ability to protect medication availability under uncertain operating conditions. The framework integrates six capabilities: Anticipate, Diversify, Buffer, Detect, Coordinate, and Recover . Anticipation identifies critical dependencies before disruption occurs; diversification reduces exposure to common points of failure; buffering provides targeted protection for medicines whose recovery or substitution may require time; detection creates an early-warning capability based on supply, inventory, and demand signals; coordination connects manufacturers, distributors, procurement teams, pharmacists, clinicians, quality functions, and regulatory actors; and recovery links restoration of supply with organizational learning. The framework emphasizes differentiated resilience strategies based on medication criticality, supply concentration, substitutability, lead time, and recovery capability instead of uniform increases in inventory or supplier numbers. Pharmacy operations are incorporated as a key interface between upstream supply conditions and clinical demand, providing evidence of emerging shortages and their operational consequences. The study further examines how strategic sourcing, risk-adjusted inventory, digital visibility, quality management, and regulatory coordination can strengthen continuity while preserving pharmaceutical standards and economic sustainability. By connecting preparedness, response, and recovery within a single management architecture, the framework provides a practical basis for strengthening pharmaceutical supply continuity in environments characterized by increasingly interconnected disruptions.

International Journal of Research PublicationsVol. 207(111)
Good health and well-being, Industry, innovation and infrastructure
Supply Chain Resilience and Risk Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon